Rockefeller Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-280
| Closed | – | – | 3043 |
|
|
2022
Q4 | $0 | Hold |
280
| – | – | ﹤0.01% | 4055 |
|
|
2022
Q3 | $0 | Hold |
280
| – | – | ﹤0.01% | 4159 |
|
|
2022
Q2 | $0 | Buy |
+280
| New | – | ﹤0.01% | 4265 |
|
|
2020
Q1 | – | Sell |
-1,100
| Closed | -$1K | – | 2430 |
|
|
2019
Q4 | $1K | Buy |
+1,100
| New | +$1K | ﹤0.01% | 1983 |
|